Post-Intensive Care Syndrome (PICS) / Long Haul COVID-19

Houston Methodist

C. M. Sevin, D. Bangalore Gotur

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

University of Colorado Department of Medicine

E. Wallace, J. Zell

What to Do When Patch Testing is Negative?

American Contact Dermatitis Society (ACDS)

M. Montanez-Wiscovich

Safety and Monitoring Considerations in Systematic Therapy

Masterclasses in Dermatology

J. Cohen

Imaging Considerations for the Dermatologist

Masterclasses in Dermatology

C. Bakewell

We Never Looked: What Happens When Gynecologic Care Ceases After Age…

Amaris Geisler

Experts Discuss Key Updates in CLL

ASH 2022 Conference Coverage

S. O'Brien, C. Coombs

Learnings From the ELEVATE-TN Phase 3 Trial: Acalabrutinib+/-Obinutu…

Alan Skarbnik

A Personalized Approach for T-Cell Lymphomas

University of Colorado Division of Hematology

B. Haverkos

ALPINE: A Randomized Phase 3 Study of Zanubrutinib vs. Ibrutinib for…

ecancer

J. Brown

Zanubrutinib for the Treatment of CLL: Learnings From ALPINE, SEQUOI…

Seema Bhat

Challenging Case: A Patient with Comorbid Solid Organ Malignancy

International Psoriasis Council (IPC)

M. Angeliki Gkini

Surveying Safety and Efficacy Data in R/R CLL: ALPINE and ELEVATE-RR…

Fred Hutchinson Cancer Center

M. Shadman

Recent Updates in CLL

Benjamin Heyman

Advances in CLL and Mantle Cell Lymphoma

Penn Medicine's 2023 Updates in Care of the Hematologic Malignancies Patient

E. Chong

2023 Updates on Sequencing in CLL

Current Challenges in Hematology

L. Scarfò

Panel Discussion on Hair, Scalp & Nail Dermatologic Conditions: How …

LivDerm

L. Stein Gold, A. W. Armstrong, D. J. Goldberg, A. Mcmichael

Chemo-Free Approaches in the Frontline Setting of CLL: Treatment Goa…

Adam Kittai